WallStreetZenWallStreetZen

NASDAQ: BOLD
Boundless Bio Inc Earnings & Revenue

BOLD earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$49.4M
Current Profit Margin
0%

BOLD Return on Equity

Insufficient data to display

Be the first to know when BOLD announces earnings.

BOLD Return on Assets

Current Company
-47.8%
Current Industry
2.9%

BOLD Return on Capital Employed

Current Company
-41.01%
Current Industry
19.5%

BOLD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABCL$38.03M-$143.14M-$146.40M+33.91%N/A
ACST$0.00-$48.89M-$38.77M-100.00%N/A
ABSI$5.72M-$95.46M-$110.57M+29.08%N/A
ABIO$0.00-$5.90M-$6.00MN/AN/A
ADIL$0.00-$5.12M-$5.12MN/AN/A

Boundless Bio Earnings & Revenue FAQ

What were BOLD's earnings last quarter?

Boundless Bio (NASDAQ: BOLD) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Boundless Bio earnings for the quarter were N/A. In the same quarter last year, Boundless Bio's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Boundless Bio stock.

What was BOLD's earnings growth in the past year?

As of Q2 2024, Boundless Bio's earnings has grown year over year. Boundless Bio's earnings in the past year totalled -$49.43 million.

What was BOLD's revenue last quarter?

Boundless Bio (NASDAQ: BOLD) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Boundless Bio's revenue was N/A.

What was BOLD's revenue growth in the past year?

As of Q2 2024, Boundless Bio's revenue has grown null year over year. Boundless Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.